<DOC>
	<DOCNO>NCT00805818</DOCNO>
	<brief_summary>The purpose study determine whether NNZ-2566 safe effective treatment Traumatic Brain Injury ( TBI ) .</brief_summary>
	<brief_title>Study NNZ-2566 Patients With Traumatic Brain Injury</brief_title>
	<detailed_description>Moderate severe traumatic brain injury frequently result persistent problem memory , attention span , mood complex brain function plan organize . There currently drug available reduce brain damage persisting symptom result TBI . The long term goal study provide physician safe effective treatment TBI .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>Nonpenetrating TBI . Male . Age 1870 year . Admission hospital . Post resuscitation GCS 412 . Have least one reactive pupil . Randomization within 7 hour injury ability receive investigational product within 8 hour injury . Hemodynamically stable resuscitation ( systolic blood pressure ( SBP ) &gt; 100 mm Hg ) . Willing undergo neuropsychological activity daily live ( ADL ) testing ( i.e . understand English , able read , write , sufficient motor dexterity , available followup visit 46 week 1214 week post injury ) . Penetrating brain injury . Spinal cord injury . Presence known history prior cerebral injury require hospitalization would , opinion Investigator , interfere bias assessment efficacy . Nontraumatic brain injury . Known history medical psychiatric disorder , severe concomitant disease , opinion Investigator would interfere bias assessment efficacy . This include following : schizophrenia ; bipolar disorder ; major depressive disorder ; post traumatic stress disorder ( PTSD ) ; generalize anxiety disorder ; attention deficit hyperactivity disorder ; neurodegenerative disease ( Alzheimer 's , Parkinson 's , Huntington 's disease , vascular dementia , Diffuse Lewy Body Disease ) ; stroke ; brain tumor ; multiple sclerosis ( MS ) ; seizure disorder ; chronic pain disorder ; alcoholism substance abuse . Significant noncentral nervous system ( CNS ) injury sustain time TBI opinion Investigator would interfere bias assessment efficacy . Weight &gt; 150 kg . Participation another clinical trial within previous 4 week . Clinical state require great 6 L colloid crystalloid fluid resuscitation prior randomization . Inability obtain informed consent legally acceptable representative . Prior enrollment study . QTc Exclusions . The study use exclusion criterion define ICH Guideline E14 exclude patient risk QT/QTc prolongation , follow : A marked baseline prolongation correct QT/QTc interval &gt; 450 ms. History risk factor torsade de pointes ( e.g . heart failure , hypokalemia ( serum potassium screening ( &lt; 3.0 mmol/L ) family history long QT syndrome ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>